Physician profile
Dawn N Conwright
NPI 1558720045
$2,825.11
in general payments reported to CMS, 2019-2025
13 companies · $229 in 2025
The $229 reported for 2025 was more than what 78% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,140 · 2022: $739 · 2023: $565 · 2024: $152 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $841.67 | 2021-2025 | Dyanavel Xr, Onyda Xr |
| Supernus Pharmaceuticals, INC. | $590.13 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $278.92 | 2021-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $229.46 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $215.64 | 2021-2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $170.94 | 2022-2023 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $149.27 | 2021-2022 | |
| Abbvie INC. | $140.86 | 2021-2025 | |
| Lundbeck LLC | $120.64 | 2022-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $34.25 | 2021 | |
| Arbor Pharmaceuticals, INC. | $23.74 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.11 | 2025 | Cobenfy |
| Collegium Pharmaceutical, INC. | $14.48 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Conwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.